10-Q/A

                                   UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                FORM 10-Q Amended


                     QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
                       OF THE SECURITIES EXCHANGE ACT OF 1934



For the quarterly period ended June 30, 1995

Commission File Number:  0-13763



                        TECHNOLOGY RESEARCH CORPORATION
                        _______________________________
             (Exact name of registrant as specified in its charter)


          Florida                                                 59-2095002
_______________________________                             ________________
(State or other jurisdiction of                             (I.R.S. Employer
 incorporation or organization)                           Identification No,)


5250 140th Avenue North, Clearwater, Florida                           34620
____________________________________________________________________________
(Address of principal executive offices)                           (Zip Code)



Registrant's telephone number, including area code  (813) 535-0572



Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for a shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.

                         YES [X]          NO [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.


            Class                               Outstanding at July 31, 1995
____________________________                    ____________________________
Common stock, $.17 par value                              15,844,507



Item 6.  Exhibits and Reports on Form 8-K

         a.  Exhibits

             Exhibit 27.  Financial Data Schedule

         b.  Reports on Form 8-K

             The Company filed no reports on Form 8-K during the quarter covered
             by this Report.


                  ___________________________________________


                                    SIGNATURES


Pursuant to the requirements of the Security Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.


                                    TECHNOLOGY RESEARCH CORPORATION
                                               (Registrant)




     Octobber 4, 1995               Robert S. Wiggins
_________________________           _______________________________
          Date                      Robert S. Wiggins, Chairman and
                                    Chief Executive Officer,
                                    Principal Financial Officer
                                    (Duly Authorized Officer)

EX-27

 

<ARTICLE>      5
<MULTIPLIER>   1
       
                                     
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                       Mar-31-1996
<PERIOD-START>                          Apr-01-1995
<PERIOD-END>                            Jun-30-1995
<CASH>                                      1113565
<SECURITIES>                                3945677
<RECEIVABLES>                               2930146
<ALLOWANCES>                                      0
<INVENTORY>                                 4022189
<CURRENT-ASSETS>                           12496451
<PP&E>                                      5719771
<DEPRECIATION>                              3328606
<TOTAL-ASSETS>                             15116139
<CURRENT-LIABILITIES>                       2081885
<BONDS>                                           0
<COMMON>                                    2693566
<PREFERRED-MANDATORY>                             0
<PREFERRED>                                       0
<OTHER-SE>                                 10003088
<TOTAL-LIABILITY-AND-EQUITY>               15116139
<SALES>                                     4244029
<TOTAL-REVENUES>                            4415990
<CGS>                                       2596028
<TOTAL-COSTS>                               2596028
<OTHER-EXPENSES>                             230240
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                            10896
<INCOME-PRETAX>                             1009670
<INCOME-TAX>                                 379814
<INCOME-CONTINUING>                          629856
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                                 629856
<EPS-PRIMARY>                                   .04
<EPS-DILUTED>                                     0